Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options

BACKGROUND: Patients newly diagnosed with lung adenocarcinoma with bone metastases (LABM) have poor survival rates after treatment with conventional therapies. To improve outcomes, we retrospectively investigated whether the application of a more comprehensive genetic test of tumor biopsies samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Long, Jiang, Xiao-Liu, Liang, Hong-Bin, Li, Jian-Cheng, Chin, Li-Han, Wei, Jian-Ping, Wang, Rui-Ru, Cai, Jing, Xiong, Qiang, Wang, Lien-Tu, Cram, David S., Liu, An-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499871/
https://www.ncbi.nlm.nih.gov/pubmed/32942985
http://dx.doi.org/10.1186/s10020-020-00197-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499871/
https://www.ncbi.nlm.nih.gov/pubmed/32942985
http://dx.doi.org/10.1186/s10020-020-00197-9

Ejemplares similares